Fundraising Fox
Glyphic Biotechnologies
Berkeley, US · Founded 2021 · Delaware corporation · 35 employees on LinkedIn · 17 known investors
Find your way into Glyphic Biotechnologies
Sign up to see every warm intro you have to Glyphic Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Glyphic Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity. The platform serves research and therapeutic development in proteomics and drug discovery.
Founders & leadership
Glyphic Biotechnologies was founded in 2021 by Daniel Estandian, Ed Boyden, and Josh Yang.
Board
Investors · 17
How we know: Artis Ventures's portfolio page · Not right? Tell us
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: FoundersX Ventures's portfolio page · Not right? Tell us
__Twitter.png)
How we know: Harpoon Ventures's portfolio page · Not right? Tell us
How we know: In-Q-Tel's portfolio page · Not right? Tell us
How we know: Modi Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: oup.vc · Not right? Tell us
How we know: StartX's portfolio page · Not right? Tell us
How we know: Valor Equity Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Wing's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$33.2M disclosed across 1 round · 2024
▶$33.2MraisedFeb 2024 · 37 investors · BiotechnologyRule 506(b)
- Joshua YangExecutive Officer, Director
- Craig AsherDirector
- Jimmy YunDirector
- Daniel EstandianExecutive Officer, Director
- Offering amount
- $52.9M
- Amount sold
- $33.2M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Glyphic Biotechnologies.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $408.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $390.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $359K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $409.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Glyphic Biotechnologies do?
- Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity. The platform serves research and therapeutic development in proteomics and drug discovery.
- Who founded Glyphic Biotechnologies?
- Glyphic Biotechnologies was founded by Daniel Estandian, Ed Boyden, Josh Yang in 2021.
- Who are Glyphic Biotechnologies's investors?
- Glyphic Biotechnologies's investors include Artis Ventures, Black Flag, Civilization Ventures Management, Llc, FoundersX Ventures, Gaingels, Harpoon Ventures, In-Q-Tel, LongeVC and 9 more.
- How much funding has Glyphic Biotechnologies raised?
- Glyphic Biotechnologies has disclosed $33.2M raised across 1 round.
- Where is Glyphic Biotechnologies headquartered?
- Glyphic Biotechnologies is headquartered in Berkeley, US.